A model for the assessment of eating problems in patients with Parkinson's diseaseA profile of the burdens of care of Alzheimer's disease patients.A rivastigmine patch for the treatment of Alzheimer's disease and Parkinson's disease dementiaAlzheimer's disease and vascular dementia. Some points of confluenceAlzheimer's disease biomarker development: a call to funding bodies.Alzheimer's disease: a molecular perspectiveAlzheimer's disease: clinical trials and drug developmentAlzheimer's disease: molecular genetics and transgenic animal models.An active and socially integrated lifestyle in late life might protect against dementiaAn integrative hypothesis concerning the pathogenesis and progression of Alzheimer's diseaseAPP mouse models for Alzheimer's disease preclinical studies.Assessing the societal impact of acetylcholinesterase inhibitor therapiesBiomarkers for Alzheimer's disease and other forms of dementia: clinical needs, limitations and future aspectsBiomarkers for Alzheimer's disease therapeutic trialsBiomarkers for apoptosis in Alzheimer's diseaseBlood pressure and dementia in the elderly: epidemiologic perspectives.Brain health: a primary health care viewpoint.CADASIL: hereditary disease of arteries causing brain infarcts and dementiaCerebrospinal fluid biomarkers in trials for Alzheimer and Parkinson diseasesCerebrospinal fluid tau and beta-amyloid(1-42) in dementia disordersClinical efficacy of piracetam in cognitive impairment: a meta-analysisClinical trials and late-stage drug development for Alzheimer's disease: an appraisal from 1984 to 2014Clinical trials in mild cognitive impairment: lessons for the futureClinical trials of potential antidepressants: to what extent are the elderly represented: a reviewCosts of dementia and dementia care: a review.Current and emerging avenues for Alzheimer's disease drug targetsCurrent and future treatment of amyloid diseasesCurrent concepts in mild cognitive impairmentDensity profiles of Alzheimer disease regional brain pathology for the huddinge brain bank: pattern recognition emulates and expands upon Braak stagingDisturbances in signal transduction mechanisms in Alzheimer's disease.Donepezil in severe Alzheimer's diseaseDonepezil treatment in severe Alzheimer's disease: a pooled analysis of three clinical trials.Early diagnosis of Alzheimer dementia based on clinical and biological factorsEconomic aspects on drug therapy of dementiaEconomic impact of introducing propentofylline for the treatment of dementia in Sweden.Editorial: EADC (European Alzheimer Disease Consortium) recommendations for future Alzheimer disease research in Europe.Environmental enrichment and the brainEnvironmental influences on brain neurotrophins in ratsEpidemiology of vascular dementia: some results despite research limitations.Erratum to: Cardiovascular medication burden in dementia disorders: a nationwide study of 19, 743 dementia patients in the Swedish Dementia Registry.
author
alumniOf
birthDate
1943-01-01T00:00:00Z
gender
knowsLanguage
nationality
worksFor
type
comment
Swedish professor
@en
Zweeds professor
@nl
ollamh Sualannach
@ga
svensk professor
@nb
label
Bengt Winblad
@ast
Bengt Winblad
@da
Bengt Winblad
@de
Bengt Winblad
@en
Bengt Winblad
@es
Bengt Winblad
@fr
Bengt Winblad
@ga
Bengt Winblad
@nb
Bengt Winblad
@nl
Bengt Winblad
@nn